Let me clarify/correct myself...apparently this grant was funded through our ongoing biomarker discovery efforts. While we have launched PPMI to validate markers that have achieved a certain level of data/justification we have maintained additional, parallel investments in finding novel biomarkers. The discovery portfolio could source candidates that could ultimately be flipped into the PPMI study infrastructure. So, I misspoke about this study already being within the PPMI world.

The Kinemed finding is a proof of concept (PD vs control). We are funding the next step (looking cross-sectionally -- do the distinctions hold in early vs mid vs late-stage PD). If the biomarkers still hold, then this would be a candidate for use of PPMI data/samples.

Still exciting but wanted to correct my statement.

Debi